CuraTeQ Biologics
Dhilip Kumar Govindaraj is an experienced biotechnology professional with a focus on downstream process development and purification processes. Currently serving as an Assistant Manager/Associate Scientist at CuraTeQ Biologics since June 2024, Dhilip Kumar previously held the position of Scientist II - DSP at Perfect Day, where responsibilities included developing purification processes for food proteins. Prior experience includes roles as an Associate Scientist at Syngene International Limited, specializing in downstream process development and technology transfer for various biotherapeutics, and a Senior Research Associate at Biocon, where work centered on peptide purification process development. Academic qualifications consist of a Master of Technology in Biotechnology and Biochemical Engineering from the Indian Institute of Technology, Kharagpur, and a Bachelor of Technology in Biotechnology from Kumaraguru College of Technology.
This person is not in the org chart
This person is not in any teams
CuraTeQ Biologics
CuraTeQ Biologics (a wholly owned subsidiary of Aurobindo Pharma Ltd.) is a biopharmaceutical company based out of Hyderabad, India. Our vision is to improve the wellbeing of patients suffering from debilitating illnesses by providing them access to high quality and cost-effective biosimilars. CuraTeQ has a development pipeline of 14 biosimilars, of which, three products have been filed with EMA, one product has been filed with MHRA, and four more products are in global phase 3 clinical trials. Our Mission: ● Deliver exceptional value to stakeholders and better health outcomes to patients by becoming a leading global biosimilars developer by 2030. ● Build deep capabilities in development and manufacturing to deliver quality and cost-effective biosimilars for patients across the globe. ● Create a sustainable and broad portfolio of biosimilars with a focus on oncology and immunology therapies.